Compare Novavax Inc (NVAX) vs Pan American Silver Corp. Common Stock (PAAS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novavax Inc vs Pan American Silver Corp. Common Stock — how do they compare? Novavax Inc trades at $12.75 (market cap $1.82B), while Pan American Silver Corp. Common Stock trades at $46.27 (market cap $18.72B). The key difference: Pan American Silver Corp. Common Stock is far larger — about 10.3× Novavax Inc's market cap, and Pan American Silver Corp. Common Stock pays a 1.62% dividend while Novavax Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Novavax Inc for 59 Days and Pan American Silver Corp. Common Stock for 1 Days on average.
| NVAX | PAAS | |
|---|---|---|
Market Cap | $1.82B | $18.72B |
Volume | 6,198,505 | 2,957,838 |
Sector | Health | Basic Materials |
52-Week High | $12.56 | $68.70 |
52-Week Low | $6.22 | $33.20 |
Typical Hold Time | 59 Days | 1 Days |
Enterprise Value | $1.39B | $17.86B |
Dividend Yield | — | 1.62% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Novavax (NVAX) trades at $11.01, down 1.87% on the day, with a bullish technical signal from moving averages and strong analyst support (73.9% buy ratings). The company reported revenue of $1.12B in 2025 with a net income of $440.3M, marking a significant turnaround from prior losses, though 2026 projections show a return to negative net income. Recent news highlights regulatory approvals for its COVID-19 vaccine and strategic pivots toward its Matrix-M adjuvant platform through partnerships.
The outlook is mixed: strong valuation ratios (P/E of 3.14, EV/EBITDA of 1.72) and recent earnings beats suggest undervaluation, but persistent cash burn and negative equity pose risks. Investment opportunity lies in partnership-driven growth, while risks include execution challenges and reliance on vaccine demand. Wall Street sentiment remains optimistic despite fundamental volatility.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →About Pan American Silver Corp. Common Stock
Pan American Silver is a mining company focused on silver and gold production in the Americas. It also explores and develops precious metals properties.
Read more on PAAS →
